In HPV+ HNSCC, patients who reacted to radiotherapy in conjunction with PD-1 antagonist showed increased GC formation, effector B cell generation, and enhanced IgG and IgM antibody responses (221). The gene discussed is PDCD1; the disease is head and neck squamous cell carcinoma.